Are pills enough? The influence of information on open-label placebo effects in healthy volunteers
Not Applicable
Completed
- Conditions
- egative emotional statePositive mental wellbeingPhysical symptomsSleep quality
- Registration Number
- ACTRN12617001092381
- Lead Sponsor
- Dr Kate Faasse
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie open-label placebo effects on mental wellbeing and sleep quality in healthy volunteers?
How does open-label placebo administration compare to standard-of-care interventions for improving physical symptoms and emotional states?
Are there specific biomarkers that predict individual response to open-label placebo treatments in ACTRN12617001092381?
What are the potential adverse events associated with open-label placebo use in clinical settings and how can they be managed?
What combination approaches or alternative therapies could enhance the effectiveness of open-label placebos for mental health outcomes?